Literature DB >> 15034158

Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome).

Pietro E G Foglia1, Alberto Bettinelli, Camillo Tosetto, Cinzia Cortesi, Laura Crosazzo, Alberto Edefonti, Mario G Bianchetti.   

Abstract

BACKGROUND: Potassium and magnesium depletion prolongs the duration of the action potential of the cardiomyocyte, which predisposes to ventricular arrhythmias. In addition, potassium or magnesium depletion might impair cardiac performance and facilitate coronary artery thrombosis.
METHODS: Continuous 24-h ambulatory electrocardiographic monitoring, treadmill exercise testing and echocardiography were assessed in 21 patients (11 female and 10 male subjects, aged 5.9-39, median 19 years) with primary renal hypokalaemia-hypomagnesaemia.
RESULTS: The QT interval corrected for heart rate was normal (between 379 and 430 ms) in 10 and slightly to moderately prolonged in the remaining 11 patients (between 446 and 509 ms). Plasma potassium, magnesium and bicarbonate were similar in patients with normal and in those with prolonged QT interval. Continuous ambulatory electrocardiography over 24 h and exercise testing did not detect significant abnormalities of cardiac rhythm or features suggestive of myocardial ischaemia. Finally, echocardiographic and Doppler assessment failed to reveal any abnormalities in myocardial morphology and function.
CONCLUSION: The QT interval is often prolonged in primary renal hypokalaemia-hypomagnesaemia, confirming that potassium and magnesium depletion tends to prolong the duration of the action potential of the cardiomyocyte. The results of continuous ambulatory electrocardiography, exercise testing and echocardiography are reassuring. Nonetheless, we assume that dangerous cardiac arrhythmias may occur in patients with very severe hypokalaemia, during medication with drugs that prolong the QT interval or in the context of short-term non-adherence to the recommended regimen of care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034158     DOI: 10.1093/ndt/gfh204

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

Review 1.  Thiazide effects and adverse effects: insights from molecular genetics.

Authors:  David H Ellison; Johannes Loffing
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

2.  [Anesthesiological management of Gitelman syndrome : Teaching example on physiology and pathophysiology of electrolyte balance].

Authors:  E Schneck; S Schaumberg; C Koch; M Rickert; C Lichtenstern
Journal:  Anaesthesist       Date:  2013-08-10       Impact factor: 1.041

3.  Monomorphic Outflow Tract Ventricular Tachycardia: Unique Presenting Manifestation of Gitelman's Syndrome.

Authors:  Subba Reddy Vanga; Chandra Annapureddy; Mazda Biria; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2010-01-01

Review 4.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

Authors:  Geoffrey K Isbister; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 5.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

6.  Cardiac arrhythmias and rhabdomyolysis in Bartter-Gitelman patients.

Authors:  Cinzia Cortesi; Sebastiano A G Lava; Alberto Bettinelli; Fabiana Tammaro; Olivier Giannini; Maria Caiata-Zufferey; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2010-06-13       Impact factor: 3.714

Review 7.  Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalities.

Authors:  T D Filippatos; C V Rizos; E Tzavella; M S Elisaf
Journal:  Int Urol Nephrol       Date:  2017-07-25       Impact factor: 2.370

8.  High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?

Authors:  L A Calò; R Montisci; R Scognamiglio; P A Davis; E Pagnin; S Schiavo; P Mormino; A Semplicini; P Palatini; A D'Angelo; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

9.  Coexistence of Gitelman Syndrome and Hypertrophic Cardiomyopathy in a Pregnant Woman.

Authors:  Abdullah Nabi Aslan; Serkan Sivri; Murat Can Güney; Telat Keleş Prof
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

10.  Ventricular arrhythmia and tachycardia-induced cardiomyopathy in Gitelman syndrome, hypokalaemia is not the only culpable.

Authors:  Rashed Al Banna; Aysha Husain; Bandar Al-Ghamdi
Journal:  BMJ Case Rep       Date:  2019-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.